EmergConnect is Transforming Access to Healthcare with the Support of Hamilton’s Life Science Ecosystem
The EmergConnect platform is transforming access to healthcare for Canadians with support from the SOPHIE program.
Evolving a Novel Approach to Cell-Based Therapies with Hamilton’s Renowned Medical Innovation Ecosystem
Allarta Life Science leverages the SOPHIE program with the goal of licensing technology and commercializing treatments.
Eye3Concepts Inc. Accelerates Commercialization Plans for its Innovative Drug Testing Device with Help from Hamilton’s Life Science Ecosystem
Eye3 has gained significant traction including securing financing, developing product concepts and prototypes and filing for patents.
Hamilton, Ontario, a long-standing leader in health and life science research and innovation, was recently recognized with a 2021 investment of $6 million from the Government of Canada, through the Federal Development Agency for Southern Ontario (FedDev Ontario). Awarded to Innovation Factory and delivered in collaboration with Synapse Consortium, the funding was used to launch […]